Ixico joins Huntington's disease research consortium
(Sharecast News) - Neuroimaging contract research provider Ixico has entered a multi-party consortium for the early detection of Huntington's disease (HD), it announced on Tuesday.
Read moreTue, 08th Feb 2022 15:17
(Sharecast News) - Neuroimaging contract research provider Ixico has entered a multi-party consortium for the early detection of Huntington's disease (HD), it announced on Tuesday.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
Read more(Sharecast News) - Medical imaging technology company Ixico said in a trading update on Monday that it expected first-half revenues of £3.9m, down from £4.9m year-on-year.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read more(Sharecast News) - Artificial intelligence (AI) neuroimaging company Ixico announced on Thursday that it has been selected by a new client to support a global prospective observational study, assessing participants for the early detection of Huntington's disease (HD).
Read more(Sharecast News) - Medical analysis company Ixico has been selected by an existing United States biotechnology client, it announced on Tuesday, to provide PET and MRI neuroimaging services for an open-label phase 1 and 2 dose-finding study.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more(Alliance News) - Shares in Ixico PLC on Monday rose after the company announced the launch of its new brain segmentation platform IXIQ Ai.
Read moreAIM WINNERS & LOSERS: Joules up on upbeat outlook; Numis quarter slow
Read moreIxico wins GBP1 million contract to provide medical imaging services
Read more(Sharecast News) - Data analytics company Ixico has extended its commitment to Dementias Platform UK (DPUK), it announced on Wednesday, as it entered its second phase.
Read moreIN BRIEF: IXICO will see 2022 revenue drop after contract canceled
Read moreAIM WINNERS & LOSERS: Parity and Brave Bison expect to beat forecasts
Read moreUK shareholder meetings calendar - next 7 days
Read more